Arcutis Biotherapeutics, Inc.ARQT

Key ratios

FCF / Sales

8.4%TTM

2025 -1.7%2024 -57.1%2023 -415.2%

Net margin

6.2%TTM

2025 -4.3%2024 -71.3%

ROA

5.1%TTM

2025 -2.0%2024 -23.3%2023 -38.1%

ROE

15.9%TTM

2025 -9.3%2024 -113.8%2023 -175.8%

Revenue growth

76.1%TTM

2025 91.3%2024 229.7%2023 1517.1%

Track ARQT in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer